Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy
ACS Macro Letters · 2024
DOI: 10.1021/acsmacrolett.4c00125 ↗Kurz gefasst
Leserbrief in der Zeitschrift ACS Macro Letters, 2024. Verfasst von Guohui Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, P. R. China. Hauptthemen laut MEDLINE: Glutathione, Photochemotherapy, Tirapazamine, Photosensitizing Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of Xuzhou Municipality, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The high glutathione (GSH) level of the tumor microenvironment severely affects the efficacy of photodynamic therapy (PDT). The current GSH depletion strategies have difficulty meeting the dual needs of security and efficiency. In this study, we report a photosensitizer Chlorin e6 (Ce6) and hypoxia-activated prodrug tirapazamine (TPZ) coloaded cross-linked multifunctional polymersome (TPZ/Ce6@SSPS) with GSH-triggered continuous GSH depletion for enhanced photodynamic therapy and hypoxia-activated chemotherapy. At tumor sites, the disulfide bonds of TPZ/Ce6@SSPS react with GSH to realize decross-linking for on-demand drug release. Meanwhile, the generated highly reactive quinone methide (QM) can further deplete GSH. This continuous GSH depletion will amplify tumor oxidative stress, enhancing the PDT effect of Ce6. Aggravated tumor hypoxia induced by PDT activates the prodrug TPZ, resulting in an enhanced combination of PDT and hypoxia-activated chemotherapy. Both in vitro and in vivo results demonstrate the efficient GSH depletion and potent antitumor activities by TPZ/Ce6@SSPS. This work provides a strategy for the design of a continuous GSH depletion platform, which holds great promise for enhanced combination tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, P. R. China.
- The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221004, P. R. China.
- Cancer Institute, Xuzhou Medical University, Xuzhou 221004, P. R. China.
- School of Life Sciences, Tianjin University, Tianjin 300072, P. R. China.
ORCID-Profile: Guohui Cheng, Sheng Wang, Dong Guo
Förderung
- Natural Science Foundation of Xuzhou Municipality
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Cheng, G., Tao, S., Liu, S., Wang, P., Zhang, C., Liu, J., Hao, C., Wang, S., Guo, D., & Xu, B. (2024). Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy. ACS Macro Letters. https://doi.org/10.1021/acsmacrolett.4c00125
Vancouver
Cheng G, Tao S, Liu S, Wang P, Zhang C, Liu J, et al. Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy. ACS Macro Letters. 2024. doi:10.1021/acsmacrolett.4c00125
BibTeX
@article{Cheng2024,
author = {Cheng, Guohui and Tao, Shuang and Liu, Shuang and Wang, Ping and Zhang, Chi and Liu, Jin and Hao, Chuanchuan and Wang, Sheng and Guo, Dong and Xu, Bo},
title = {Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy},
journal = {ACS Macro Letters},
year = {2024},
doi = {10.1021/acsmacrolett.4c00125}
}
EUVIMED